Medicine:MiraDry
miraDry is a microwave-based medical device developed by Miramar Labs which is used in the treatment of axillary hyperhidrosis.[1] It was approved by the US Food and Drug Administration (FDA) in 2011 and was also approved in Europe.[1] miraDry selectively destroys axillary sweat glands without affecting the superficial layers of the skin.[1] In addition to sweat glands, miraDry destroys hair follicles in the axillary region regardless of hair color.[1] It is about 72.5 to 90% effective[2] and sweat is reduced by about 82% on average.[3] It also reduces axillary hair by about 75%.[4] The effects of miraDry are noticeable almost immediately and are long-lasting or permanent.[1] A case of death due to miraDry caused by necrotizing fasciitis that was complicated by streptococcal toxic shock syndrome has been reported.[5][6]
References
- ↑ 1.0 1.1 1.2 1.3 1.4 "Potential use of microwave technology in dermatology". J Dermatolog Treat 33 (7): 2899–2910. November 2022. doi:10.1080/09546634.2022.2089333. PMID 35699665.
- ↑ "Treatment of Axillary hyperhidrosis". J Cosmet Dermatol 21 (1): 62–70. January 2022. doi:10.1111/jocd.14378. PMID 34416078. https://boris.unibe.ch/164284/.
- ↑ "Treatment of hyperhidrosis with microwave technology". Semin Cutan Med Surg 32 (1): 2–8. March 2013. PMID 24049923.
- ↑ "Home - miraDry". https://corp.miradry.com/wp-content/uploads/2023/03/LB0322.D-MD4000-MC-User-Manual-freshConnect.pdf.
- ↑ "New developments in cosmetic applications of electromagnetic fields: Client and occupational hazard assessment". Bioelectromagnetics. March 2024. doi:10.1002/bem.22503. PMID 38533721.
- ↑ "Fatal consequence after MiraDry® treatment: Necrotizing fasciitis complicated with streptococcal toxic shock syndrome". Leg Med (Tokyo) 58. September 2022. doi:10.1016/j.legalmed.2022.102095. PMID 35662070.
 |  |
